Therapix stock: buy or sell?

TRPX stock price: $0.46 -11.54% At close on February 26th, 2020

Updated on:
February 26th, 2020

0

Shares of Therapix ended today at $0.46 and plunged a dreadful -11.54%.

Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules.

Should I buy Therapix stock?

Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Following a trading plan helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

Currently, Therapix stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean TRPX will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Therapix stock a buy?

Banks and financial institutions publish stock ratings everyday. Unfortunately, we couldn't detect any rating for TRPX stock for the last month.

Therapix stock analysis

Daily outlook

Shares of Therapix Biosciences plunged a dreadful -11.54% and closed at $0.46.

Therapix shares plunged -11.54% to $0.46 today.

TRPX stock chart (daily)

Weekly outlook

Therapix Biosciences ended this week at $0.46 and collapsed a spooky -6.12%. By mid February TRPX rocketed a super good 11.76% in just one week.

Since mid March 2019, when TRPX stock price broke down the 40-weeks moving avarage line, it slid $-4.09 per share (-89.89%). Trading stocks that are below the 40-weeks (that is, 200-days) moving average mark is not recommended by many experts, as it indicates that the stock has not enough institutional support.

TRPX stock chart (weekly)

Therapix stock price history

Therapix IPO was on March 22nd, 2017 at $6.30 per share1. Since then, TRPX stock lost a -92.70%, with a yearly average of -46.40%.

1: Adjusted price after possible price splits or reverse-splits.

Therapix stock historical price chart

TRPX stock reached 52-week highs on March at $4.80, and all-time highs 2017-03-23 with a price of 10.95.

Therapix stock price target

Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. You should not follow the analysts' TRPX stock price predictions in the hope that they will be met as they may be wrong and not met. For the last month we have not found any price target for Therapix stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

, when Therapix Biosciences published its last earnings report, it . Unfortunately, reported EPS is not yet available in our database.
TRPX earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2016-Q4-n/an/an/a
2017-Q1-n/an/an/a
2017-Q2-n/an/an/a
2017-Q3-n/an/an/a
2017-Q42018-04-30n/a0.83n/a
2018-Q12018-05-31n/a0.59n/a
2018-Q22018-08-20n/a-0.35n/a
2018-Q32018-12-03n/a-0.5n/a
2018-Q4-n/an/an/a
2019-Q1-n/an/an/a

Annual financial results

In , Therapix Biosciences annual turnover to million USD from marked in . , its income margin (compared to sales) to , that is million.

TRPX annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY

Quarterly financial results

Reported quarter earnings marked $-1.74 million with a profit margin of . Profit margin stayed stable a 0.00% compared to previous quarter when profit margin was inf%. When comparing sales to same quarter last year, Therapix Biosciences sales marked a tight move and stayed steady a nan%. Looking back to recent quarterly results, Therapix Biosciences posted 5 negative quarters in a row.
TRPX quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2

Therapix ownership

When you are planning to invest in a stock, it's worth to review its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Therapix, 9.73% of all outstanding shares are owned by its staff.

In case of Therapix Biosciences stock, 0.00% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for TRPX stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Therapix:

TRPX
Market cap$3.3 M
Total shares7.2 M
Float shares4.1 M
  - Institutional holdings (%)0.0%
  - Insider holdings (%)9.7%
Shares in short selling0.0%

Therapix summary

Wednesday, February 26th, 2020
Open$0.50
Close$0.46
Day range$0.45 - $0.53
Previous close$0.52
Session gain-11.54%
Average true range$0.07
50d mov avg$0.76
100d mov avg$1.38
200d mov avg$2.01
Daily patternlt01a
Weekly pattern lb06a

Therapix performance

To measure stock performance is always good to benchmark with competitors or related stocks. In the following table, we compare Therapix Biosciences to :
Stock3m6m12m
TRPXTherapix Bioscien...-70.89%-81.96%-90.02%

Therapix competitors

Unfortunately, we could not find any public company that could be defined as Therapix competitor. This doesn't mean Therapix does not have any competitor in the market, it's just we could not detected it.